Bone marrow cell therapy - DNAmicroarrayAlternative Names: Cardiac stem cell therapy - DNAmicroarray; EBMS; Enhanced bone marrow stem cell therapy; Heart cell therapy - DNAmicroarray
Latest Information Update: 01 Aug 2016
At a glance
- Originator DNAmicroarray
- Class Cell therapies; Heart failure therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Heart failure
Most Recent Events
- 01 Aug 2016 Preclinical trials in Heart failure in USA (Parenteral)